Toggle navigation
Home
Search
Services
Blog
Contact
About
Liposomes with Biological Response Modifiers for Therapy
Swenson, Karl E.
Entara Corporation, Moorhead, MN, United States
Search grants from Karl Swenson
Search grants from Entara Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Innovative Personal Monitoring Approaches to Characterize Ultrafine and Fine Particulate Matter and Respiratory Health Effects
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.
Dynamics of Translation
Development of Perceptual Organization in Infancy
Logistical Support for Research Planning
Recently added grants:
Role of METTL3 and the m6A Epitranscriptome in cancer
Understanding the mechanism of bone marrow stromal cell-mediated protection of FLT3-ITD AML from FLT3-targeted therapy
The role of a novel fusion oncogene FYN-TRAF3IP2 in peripheral T-cell lymphoma
Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057796-000
Application #
3613406
Study Section
Project Start
1985-09-24
Project End
Budget Start
1985-09-24
Budget End
1986-03-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Entara Corporation
Department
Type
DUNS #
City
Moorhead
State
MN
Country
United States
Zip Code
56560
Comments
Be the first to comment on Karl Swenson's grant